For: | Zhang Y, Li JX, Zhang Y, Wang YL. Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis . World J Clin Cases 2021; 9(23): 6654-6662 [PMID: 34447812 DOI: 10.12998/wjcc.v9.i23.6654] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i23/6654.htm |
Number | Citing Articles |
1 |
Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Lan Xintian. The gut-liver axis in fatty liver disease: role played by natural products. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1365294
|
2 |
Yiming Cao, Xiaoxue Fang, Mingyang Sun, Yegang Zhang, Mengyao Shan, Xintian Lan, Difu Zhu, Haoming Luo. Preventive and therapeutic effects of natural products and herbal extracts onnonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Phytotherapy Research 2023; 37(9): 3867 doi: 10.1002/ptr.7932
|
3 |
Zhengdou Li, Xueqi Wang, Xu Li, Xia Chen, Cancan Wang, Ying Mao, Guixiang Teng, Xinliang Zhu, Ji Zhang. Polysaccharides from Lanzhou Lily Attenuate Nonalcoholic Fatty Liver Disease Modifying the Gut Microbiota and Metabolite Profile. Chemistry & Biodiversity 2024; doi: 10.1002/cbdv.202401538
|
4 |
Tong Xu, Ruijie Sun, Yuchen Zhang, Chen Zhang, Yujing Wang, Zhuo A. Wang, Yuguang Du. Recent Research and Application Prospect of Functional Oligosaccharides on Intestinal Disease Treatment. Molecules 2022; 27(21): 7622 doi: 10.3390/molecules27217622
|